Literature DB >> 15503038

Early modifications of hepatic perfusion measured by functional CT in a rat model of hepatocellular carcinoma using a blood pool contrast agent.

Laure S Fournier1, Charles Andre Cuenod, Cedric de Bazelaire, Nathalie Siauve, Christophe Rosty, Phuong Lan Tran, Guy Frija, Olivier Clement.   

Abstract

Macromolecular contrast-enhanced functional CT was performed to characterize early perfusion changes in hepatocellular carcinoma (HCC). Fourteen rats with chemically induced primary liver tumors ranging pathologically from hyperplasia to HCC and 15 control rats were investigated. Two dynamic CT scans using an experimental macromolecular contrast agent were performed on a single slice 11 and 18 weeks after tumor induction followed by pathological examination. A deconvolution mathematical model was applied, yielding the hepatic perfusion index (HPI), mean transit time (MTT), liver distribution volume (LDV) and arterial, portal and total blood flows (FA, FP, FT). Analysis was performed on one slice per rat, containing overall two hyperplasia, six dysplasia and 15 HCC. On the first scans, HCC at an early pathological stage had a low FP (-30%, P=0.002) but a normal arterial-portal balance. On the scan contemporary to pathology, HCC perfusion parameters showed an inversion of the arterial-portal balance (HPI +212%, P<0.0001), with a high FA (+56%, P=0.002) and a low FP (-69%, P<0.0001). Sensitivity and specificity of detection of HCC by perfusion CT were high (87 and 80%) on late scans; but also on the earlier scans (86 and 65%), even though only one (7%) was visible to the eye. Perfusion-CT allowed early detection of HCC. This technique could contribute in the detection and characterization of liver lesions in clinical studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15503038     DOI: 10.1007/s00330-004-2339-8

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  16 in total

1.  Preclinical profile of the monodisperse iodinated macromolecular blood pool agent P743.

Authors:  J M Idée; M Port; P Robert; I Raynal; P Prigent; A Dencausse; S Le Greneur; I Tichkowsky; G Le Lem; P Bourrinet; T Mugel; S Benderbous; L Devoldere; R Bourbouze; D Meyer; B Bonnemain; C Corot
Journal:  Invest Radiol       Date:  2001-01       Impact factor: 6.016

Review 2.  Tumor angiogenesis: tutorial on implications for imaging.

Authors:  T J Passe; D A Bluemke; S S Siegelman
Journal:  Radiology       Date:  1997-06       Impact factor: 11.105

3.  Expression and localization of vascular endothelial growth factor receptors in human hepatocellular carcinoma and non-HCC tissues.

Authors:  R Yamaguchi; H Yano; Y Nakashima; S Ogasawara; K Higaki; J Akiba; D J Hicklin; M Kojiro
Journal:  Oncol Rep       Date:  2000 Jul-Aug       Impact factor: 3.906

4.  Quantitative studies on the developing vascular system of rat hepatoma.

Authors:  H Yamaura; H Sato
Journal:  J Natl Cancer Inst       Date:  1974-11       Impact factor: 13.506

5.  Microcirculation of hepatic nodules from diethylnitrosamine-treated rats.

Authors:  J G Conway; J A Popp; R G Thurman
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

6.  Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.

Authors:  J Trojan; O Schroeder; J Raedle; R P Baum; G Herrmann; V Jacobi; S Zeuzem
Journal:  Am J Gastroenterol       Date:  1999-11       Impact factor: 10.864

Review 7.  Diagnostic imaging and interventional therapy of hepatocellular carcinoma.

Authors:  L D Palma
Journal:  Br J Radiol       Date:  1998-08       Impact factor: 3.039

8.  Non-linearity of neoplastic conversion induced in rat liver by low exposures to diethylnitrosamine.

Authors:  G M Williams; R Gebhardt; H Sirma; F Stenbäck
Journal:  Carcinogenesis       Date:  1993-10       Impact factor: 4.944

9.  Dynamic computed tomography with low- and high-molecular-mass contrast agents to assess microvascular permeability modifications in a model of liver fibrosis.

Authors:  Roland Materne; Laurence Annet; Stéphane Dechambre; Christine Sempoux; Anne M Smith; Claire Corot; Yves Horsmans; Bernard E Van Beers
Journal:  Clin Sci (Lond)       Date:  2002-08       Impact factor: 6.124

Review 10.  Hepatocellular carcinoma: update on diagnosis and treatment.

Authors:  W H Ramsey; G Y Wu
Journal:  Dig Dis       Date:  1995 Mar-Apr       Impact factor: 2.404

View more
  23 in total

Review 1.  Clinical application of hepatic CT perfusion.

Authors:  Liang Zhong; Wen-Jing Wang; Jian-Rong Xu
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

2.  Renal perfusion and hemodynamics: accurate in vivo determination at CT with a 10-fold decrease in radiation dose and HYPR noise reduction.

Authors:  Xin Liu; Andrew N Primak; James D Krier; Lifeng Yu; Lilach O Lerman; Cynthia H McCollough
Journal:  Radiology       Date:  2009-10       Impact factor: 11.105

Review 3.  Perfusion magnetic resonance imaging of the liver.

Authors:  Choon Hua Thng; Tong San Koh; David J Collins; Dow Mu Koh
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

4.  Perfusion characterization of liver metastases from endocrine tumors: Computed tomography perfusion.

Authors:  Aurélie Guyennon; Marius Mihaila; John Palma; Catherine Lombard-Bohas; Jean-Alain Chayvialle; Frank Pilleul
Journal:  World J Radiol       Date:  2010-11-28

Review 5.  Recent Advances in CT and MR Imaging for Evaluation of Hepatocellular Carcinoma.

Authors:  Jeong Min Lee; Jeong-Hee Yoon; Ijin Joo; Hyun Sik Woo
Journal:  Liver Cancer       Date:  2012-06       Impact factor: 11.740

6.  Usefulness of a dual-input single-compartment model for quantitative evaluation of thioacetamide-induced acute liver injury in rats using dynamic contrast-enhanced computed tomography.

Authors:  Shuichiro Kobayashi; Akihiro Kitamura; Taro Matsushita; Motoko Nishiura; Kenya Murase
Journal:  Radiol Phys Technol       Date:  2011-08-20

7.  The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients.

Authors:  Martijn R Meijerink; Hester van Cruijsen; Klaas Hoekman; Matthijs Kater; Cors van Schaik; Jan Hein T M van Waesberghe; Giuseppe Giaccone; Radu A Manoliu
Journal:  Eur Radiol       Date:  2006-10-27       Impact factor: 5.315

8.  Correlation of histological findings from a large ciliochoroidal melanoma with CT perfusion and 3T MRI dynamic enhancement studies.

Authors:  Jose S Pulido; Norbert G Campeau; Ernst Klotz; Andrew N Primak; Osama Saba; Kaan Gunduz; Herbert Cantrill; Diva Salomão; Cynthia H McCollough
Journal:  Clin Ophthalmol       Date:  2008-06

9.  Encapsulated hepatocellular carcinoma: CT-pathologic correlations.

Authors:  Jae Hoon Lim; Dongil Choi; Cheol Keun Park; Won Jae Lee; Hyo Keun Lim
Journal:  Eur Radiol       Date:  2006-03-18       Impact factor: 5.315

10.  Establishing models of portal vein occlusion and evaluating value of multi-slice CT in hepatic VX2 tumor in rabbits.

Authors:  Yue-Yong Qi; Li-Guang Zou; Ping Liang; Dong Zhang
Journal:  World J Gastroenterol       Date:  2007-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.